Design, Synthesis, and Biological Evaluation of Tetra‐Substituted Thiophenes as Inhibitors of p38α MAPK
Open Access
- 11 November 2014
- journal article
- research article
- Published by Wiley in ChemistryOpen
- Vol. 4 (1) , 56-64
Abstract
P38α mitogen‐activated protein kinase (MAPK) plays a role in several cellular processes and consequently has been a therapeutic target in inflammatory diseases, cancer, and cardiovascular disease. A number of known p38α MAPK inhibitors contain vicinal 4‐fluorophenyl/4‐pyridyl rings connected to either a 5‐ or 6‐membered heterocycle. In this study, a small library of substituted thiophene‐based compounds bearing the vicinal 4‐fluorophenyl/4‐pyridyl rings was designed using computational docking as a visualisation tool. Compounds were synthesised and evaluated in a fluorescence polarisation binding assay. The synthesised analogues had a higher binding affinity to the active phosphorylated form of p38α MAPK than the inactive nonphosphorylated form of the protein. 4‐(2‐(4‐fluorophenyl)thiophen‐3‐yl)pyridine had a Ki value of 0.6 μm to active p38α MAPK highlighting that substitution of the core ring to a thiophene retains affinity to the enzyme and can be utilised in p38α MAPK inhibitors. This compound was further elaborated using a substituted phenyl ring in order to probe the second hydrophobic pocket. Many of these analogues exhibited low micromolar affinity to active p38α MAPK. The suppression of neonatal rat fibroblast collagen synthesis was also observed suggesting that further development of these compounds may lead to potential therapeutics having cardioprotective properties.Keywords
This publication has 39 references indexed in Scilit:
- The p38 mitogen-activated protein kinase pathway—A potential target for intervention in infarction, hypertrophy, and heart failureJournal of Molecular and Cellular Cardiology, 2011
- Mitogen-activated Protein Kinase (MAPK) Phosphatase 3-mediated Cross-talk between MAPKs ERK2 and p38αJournal of Biological Chemistry, 2011
- Celecoxib, but not rofecoxib or naproxen, attenuates cardiac hypertrophy and fibrosis induced in vitro by angiotensin and aldosteroneClinical and Experimental Pharmacology and Physiology, 2010
- Charakterisierung der Dynamik der Kinase p38 in freiem und ligandgebundenem Zustand durch NMR‐SpektroskopieAngewandte Chemie, 2005
- p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the ratJACC, 2004
- p38α Mitogen-Activated Protein Kinase Inhibition Improves Cardiac Function and Reduces Myocardial Damage in Isoproterenol-Induced Acute Myocardial Injury in RatsJournal of Cardiovascular Pharmacology, 2004
- p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseasesNature Reviews Drug Discovery, 2003
- Inositol Polyphosphate 1-Phosphatase Is a Novel Antihypertrophic FactorJournal of Biological Chemistry, 2002
- Specificity and mechanism of action of some commonly used protein kinase inhibitorsBiochemical Journal, 2000
- The Protein Data BankNucleic Acids Research, 2000